Whitney K. Hendrickson
( out of 117 reviews )

Whitney K. Hendrickson, MD

Languages spoken: English

Clinical Locations

University of Utah Hospital

Urogynecology, Area E
Salt Lake City
801-213-2995
Directions

  • Dr. Whitney Hendrickson is a specialized urogynecologist dedicated to women's health. She focuses on both medical and surgical treatments for pelvic organ prolapse, urinary incontinence, and fecal incontinence. She offers minimally invasive robotic surgery for prolapse and sacral neuromodulation for conditions like urgency incontinence, fecal incontinence, and urinary retention.

    Dr. Hendrickson, who works in the Division of Urogynecology and Pelvic Reconstructive Surgery at the University of Utah Health, is currently accepting new patients with pelvic floor disorders.

    Dr. Hendrickson earned her medical degree from the University of Massachusetts and completed her Obstetrics & Gynecology residency at UC San Diego. She then pursued advanced training with a fellowship in Urogynecology and Pelvic Reconstructive Surgery (formerly called Female Pelvic Medicine and Reconstructive Surgery) at Duke University.

    In addition to her clinical work, Dr. Hendrickson is involved in quality improvement, clinical research, and medical education. She is the founder and chair of the Gynecology Quality Improvement and Patient Safety Committee, aimed at improving surgical outcomes for all gynecologic surgeries at the University of Utah.

    Her research is aimed at improving treatment outcomes for pelvic floor disorders, mostly focused on overactive bladder and lower urinary tract symptoms. She has developed tools to help both patients and clinicians make informed treatment decisions, particularly in managing urgency urinary incontinence and predicting post-surgical complications.

    As a Eunice Kennedy Shriver National Institute of Child Health and Human Development Women’s Reproductive Health Research (WRHR) K12 scholar, she is studying the outcomes of treatments for urgency urinary incontinence, including OnabotulinumtoxinA (BOTOX®) and sacral neuromodulation (SNM) to understand who will respond best to which therapy. She is also involved in medical student and resident education mostly focusing on surgical didactics.

    Specialties

    Board Certification

    American Board of Obstetrics & Gynecology (Obstetrics & Gynecology)

    Patient Rating

    5.0 /5
    ( out of 117 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    January 23, 2025
    UNIVERSITY HOSPITAL

    The medical was amazing and provided answers to a problem that other practitioners overlooked for several years. The professionalism and knowledge is highly unmatched and I was sad to find out that the facility is out of network for my insurance leaving me to seek treatment elsewhere. I can't thank this team enough for at least providing answers.

    January 22, 2025
    UNIVERSITY HOSPITAL

    Dr. Hendrickson provided excellent care from my first appointment. She explained clearly what my condition was and the surgical and non-surgical options available. She supported my decisions and accommodated my specific needs. Her surgery skills were excellent making my recovery much better than I expected - - almost easy!

    January 08, 2025
    UNIVERSITY HOSPITAL

    Excellent, knowledgeable, personable physician. I appreciate that!

    December 19, 2024
    UH HOSPITALS AND CLINICS

    Dr. Hendricks and her assistants were great. She took the time to answer my questions and tailored her care to my specific needs.

    December 19, 2024
    UH HOSPITALS AND CLINICS

    I am very thankful to be treated by Dr Hendrickson. She is an excellent diagnostician, explains everything very well, is very kind, and personable. I highly recommend her to help you.

    December 05, 2024
    UH HOSPITALS AND CLINICS

    I was very impressed with Dr. Hendrickson. She was thorough, patient with my many questions, and made me feel at ease. I felt that we made informed decisions about my care as a team. Very grateful to be her patient.

    October 30, 2024
    UH HOSPITALS AND CLINICS

    Thorough and caring

    October 10, 2024
    UH HOSPITALS AND CLINICS

    Dr. Hendrickson is a knowledgeable and kind physician who I trust with my care.

    October 09, 2024
    UH HOSPITALS AND CLINICS

    she is great! very patient and understanding.

  • Dr. Whitney Hendrickson is a specialized urogynecologist dedicated to women's health. She focuses on both medical and surgical treatments for pelvic organ prolapse, urinary incontinence, and fecal incontinence. She offers minimally invasive robotic surgery for prolapse and sacral neuromodulation for conditions like urgency incontinence, fecal incontinence, and urinary retention.

    Dr. Hendrickson, who works in the Division of Urogynecology and Pelvic Reconstructive Surgery at the University of Utah Health, is currently accepting new patients with pelvic floor disorders.

    Dr. Hendrickson earned her medical degree from the University of Massachusetts and completed her Obstetrics & Gynecology residency at UC San Diego. She then pursued advanced training with a fellowship in Urogynecology and Pelvic Reconstructive Surgery (formerly called Female Pelvic Medicine and Reconstructive Surgery) at Duke University.

    In addition to her clinical work, Dr. Hendrickson is involved in quality improvement, clinical research, and medical education. She is the founder and chair of the Gynecology Quality Improvement and Patient Safety Committee, aimed at improving surgical outcomes for all gynecologic surgeries at the University of Utah.

    Her research is aimed at improving treatment outcomes for pelvic floor disorders, mostly focused on overactive bladder and lower urinary tract symptoms. She has developed tools to help both patients and clinicians make informed treatment decisions, particularly in managing urgency urinary incontinence and predicting post-surgical complications.

    As a Eunice Kennedy Shriver National Institute of Child Health and Human Development Women’s Reproductive Health Research (WRHR) K12 scholar, she is studying the outcomes of treatments for urgency urinary incontinence, including OnabotulinumtoxinA (BOTOX®) and sacral neuromodulation (SNM) to understand who will respond best to which therapy. She is also involved in medical student and resident education mostly focusing on surgical didactics.

    Board Certification and Academic Information

    Academic Departments Obstetrics & Gynecology -Assistant Professor (Clinical)
    Academic Divisions Urogynecology
    Board Certification
    American Board of Obstetrics & Gynecology (Obstetrics & Gynecology)

    Education history

    Fellowship Urogynecology and Reconstructive Pelvic Surgery (Formerly Female Pelvic Medicine and Reconstructive Surgery) - Duke University Medical Center Fellow
    Internship/Residency Gynecology & Reproductive Science - University of California, San Diego School of Medicine Administrative Chief Resident
    Residency Integrative Medicine Elective - University of Arizona College of Medicine Visiting Resident
    Internship/Residency Obstetrics & Gynecology - University of California San Diego Medical Center Intern/Resident
    Professional Medical Medicine; concentration in Multicultural Pathways - University of Massachusetts Medical School M.D.
    Undergraduate Molecular Biology & Biochemistry (High honors, cum laude) - Middlebury College B.A.

    Selected Publications

    Journal Article

    1. Hendrickson WK, Zhang C, Hokanson JA, Nygaard IE, Presson AP (2024). Predicting success using response after lead implantation with sacral neuromodulation for urgency incontinence. Neurourol Urodyn, 43(8), 1776-1783. (Read full article)
    2. Hendrickson WK, Zhang C, Jelovsek JE, Nygaard IE, Presson AP (2023). Longitudinal Fluctuations in Treatment Response After OnabotulinumToxinA and Sacral Neuromodulation for Refractory Urgency Incontinence. J Urol, 211(1), 134-143. (Read full article)
    3. Hendrickson WK, Zhang C, Jelovsek JE, Nygaard IE, Presson AP (2024). Reply by Authors. J Urol, 211(1), 142-143. (Read full article)
    4. Hendrickson WK, Allshouse AA, Nygaard IE, Swenson CW (2023). Overactive Bladder in Late Pregnancy to 1 Year After First Vaginal Delivery. Urogynecology (Phila), 30(4), 433-442. (Read full article)
    5. Lai HH, Wiseman JB, Helmuth ME, Smith AR, Amundsen CL, Cameron AP, Glaser AP, Hendrickson WK, Kirkali Z, Kenton K (2022). Phenotyping of Urinary Urgency Patients without Urgency Incontinence, and Their Comparison to Urgency Incontinence Patients: Findings from the LURN Study. J Urol, 209(1), 233-242. (Read full article)
    6. Kowalski JT, Wiseman JB, Smith AR, Helmuth ME, Cameron A, DeLancey JOL, Hendrickson WK, Jelovsek JE, Kirby A, Kreder K, Lai HH, Mueller M, Siddiqui N, Bradley CS (2022). Natural history of lower urinary tract symptoms in treatment-seeking women with pelvic organ prolapse; the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN). Am J Obstet Gynecol, 227(6), 875.e1-875.e12. (Read full article)
    7. Hendrickson WK, Xie G, Rahn DD, Amundsen CL, Hokanson JA, Bradley M, Smith AL, Sung VW, Visco AG, Luo S, Jelovsek JE (2021). Predicting outcomes after intradetrusor onabotulinumtoxina for non-neurogenic urgency incontinence in women. Neurourol Urodyn, 41(1), 432-447. (Read full article)
    8. Hendrickson WK, Havrilesky L, Siddiqui NY (2021). Cost-effectiveness of bacteriuria screening before urogynecologic surgery. Am J Obstet Gynecol, 226, 831.e1-831.e12. (Read full article)
    9. Harvie HS, Sung VW, Neuwahl SJ, Honeycutt AA, Meyer I, Chermansky CJ, Menefee S, Hendrickson WK, Dunivan GC, Mazloomdoost D, Bass SJ, Gantz MG, Eunice Kennedy Shriver National Institute of Child Health and Human Development Pelvic Floor Disorders Network (2021). Cost-effectiveness of behavioral and pelvic floor muscle therapy combined with midurethral sling surgery vs surgery alone among women with mixed urinary incontinence: results of the Effects of Surgical Treatment Enhanced With Exercise for Mixed Urinary Incontinence randomized trial. Am J Obstet Gynecol, 225(6), 651.e1-651.e26. (Read full article)
    10. Hendrickson WK, Amundsen CL, Rahn DD, Meyer I, Bradley MS, Smith AL, Myers DL, Jelovsek JE, Lukacz ES (2021). Comparison of 100 U With 200 U of Intradetrusor OnabotulinumToxinA for Nonneurogenic Urgency Incontinence. Female Pelvic Med Reconstr Surg, 27(3), 140-146. (Read full article)
    11. Hendrickson WK, Amundsen CL (2021). Sacral neuromodulation: troubleshooting needle placement. Int Urogynecol J, 32, 2549-2551. (Read full article)
    12. Hendrickson WK, Amundsen CL (2020). Sacral neuromodulation: sacral anatomy and optimal lead placement. Int Urogynecol J, 32, 2545-2547. (Read full article)
    13. Hendrickson WK, Amundsen CL (2019). 2019 Update on pelvic floor dysfunction: review of fecal incontinence treatments. 31(9), 23, 24, 26-30.
    14. Downey JS, Mashburn-Warren L, Ayala EA, Senadheera DB, Hendrickson WK, McCall LW, Sweet JG, Cvitkovitch DG, Spatafora GA, Goodman SD (2014). In vitro manganese-dependent cross-talk between Streptococcus mutans VicK and GcrR: implications for overlapping stress response pathways. PLoS One, 9(12), e115975. (Read full article)
    15. Flavin R, Pettersson A, Hendrickson WK, Fiorentino M, Finn S, Kunz L, Judson GL, Lis R, Bailey D, Fiore C, Nuttall E, Martin NE, Stack E, Penney KL, Rider JR, Sinnott J, Sweeney C, Sesso HD, Fall K, Giovannucci E, Kantoff P, Stampfer M, Loda M, Mucci LA (2014). SPINK1 protein expression and prostate cancer progression. Clin Cancer Res, 20(18), 4904-11. (Read full article)
    16. Kasperzyk JL, Finn SP, Flavin R, Fiorentino M, Lis R, Hendrickson WK, Clinton SK, Sesso HD, Giovannucci EL, Stampfer MJ, Loda M, Mucci LA (2013). Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer. Cancer Epidemiol Biomarkers Prev, 22(12), 2354-63. (Read full article)
    17. Hendrickson WK, Flavin R, Kasperzyk JL, Fiorentino M, Fang F, Lis R, Fiore C, Penney KL, Ma J, Kantoff PW, Stampfer MJ, Loda M, Mucci LA, Giovannucci E (2011). Vitamin D receptor protein expression in tumor tissue and prostate cancer progression. J Clin Oncol, 29(17), 2378-85. (Read full article)
    18. Fang F, Kasperzyk JL, Shui I, Hendrickson W, Hollis BW, Fall K, Ma J, Gaziano JM, Stampfer MJ, Mucci LA, Giovannucci E (2011). Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer. PLoS One, 6(4), e18625. (Read full article)

    Book Chapter

    1. Whitney K Hendrickson and Matthew D Barber (). Chapter 19: Surgical Treatment of Anterior Vaginal Wall Prolpase. In Matthew D. Barber; Mark D. Walters; Mickey M. Karram; Catherine Bradley (Ed.), Walters & Karram Urogynecology and Reconstructive Pelvic Surgery (6th). Elsevier.
    2. Hendrickson WK and MD Barber (2023). Chapter 8.2 Anterior Vaginal Wall Prolapse. In Linda Cardozo, M.D. and David R. Staskin, M.D (Eds.), Textbook of Female Urology and Urogynecology: Surgical Perspectives (5th ed). CRC Press.

    Letter

    1. Swenson CW, Hendrickson WK, Allshouse AA, Nygaard IE (2024). Older maternal age at first vaginal delivery is associated with increased genital hiatus size at 1 year postpartum. [Letter to the editor]. Am J Obstet Gynecol, 230(6), e110-e112. (Read full article)

  • News & Podcasts

    Podcasts